TFA Therapeutics Company Description

TFA Therapeutics, Inc. develops TFA-01 novel nonsteroidal anti-inflammatory drugs for pet medical care.

It offers drugs in the areas of canine osteoarthritis, dermatitis, and feline stomatitis. The company serves customers in Taiwan, Japan, Greater China, and United States.

TFA Therapeutics, Inc. was formerly known as Cordyceps Sunshine Biotech Holdings Co., Ltd. and changed its name to TFA Therapeutics, Inc. in July 2026.

The company was incorporated in 2020 and is based in Taipei, Taiwan.

TFA Therapeutics, Inc.

Country	Cayman Islands
Founded	2020
Industry	Packaged Foods
Sector	Consumer Staples
Employees	16
CEO	Szu Hao Huang

Contact Details

Address: No. 15, Lane 548 Taipei, 114063 Taiwan
Phone	886 2 2748 9091
Website	tfabio.com

Stock Details

Ticker Symbol	RAJAF
Exchange	OTCMKTS
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	USD
SIC Code	2834

Key Executives

Name	Position
Szu Hao Huang	Director, Chief Executive Officer and Chief Financial Officer